Ambey Laboratories IPO
IPO Listing Details
- Listing Date
11 Jul 2024
- Listing Price
₹ 85.00
- Listing Change
25.00%
- Last Traded Price
₹ 62.70
IPO Details
- Open Date
04 Jul 2024
- Close Date
08 Jul 2024
- IPO Price Range
₹ 65 to ₹ 68
- IPO Size
₹ 44.68 Cr
- Listing Exchange
NSE SME
- Listing Date
11 Jul 2024
IPO Timeline
Ambey Laboratories IPO Subscription Status
| Date | QIB | NII | Retail | TOTAL |
|---|---|---|---|---|
| 04-Jul-24 | 0.41 | 19.80 | 28.47 | 18.48 |
| 05-Jul-24 | 0.41 | 50.31 | 64.63 | 42.59 |
| 08-Jul-24 | 61.90 | 324.02 | 194.18 | 172.67 |
Last Updated: 09 July 2024 11:02 AM by 5Paisa
Last Updated: 8th July 2024, 18:05 PM by 5paisa
Ambey Laboratories IPO is all set to open from 4th July to 8th July 2024. The company manufactures agrochemical products. The IPO includes a fresh issue of 6,552,000 shares and an Offer for Sale of 312,000 shares. The share allotment date is 9th July and the IPO listing date is 11th July. The price band is ₹65 to ₹68 per share and the lot size is 2000 shares.
Fast Track Finsec Private Limited is the book-running lead manager for this IPO, while Link Intime India Private Limited is the registrar.
Objectives of Ambey Lab IPO
Ambey Laboratories Limited plans to utilize the raised capital from the IPO to:
● To fund Working Capital Requirements.
● General corporate purposes.
● To fund the public issue expenses.
Ambey Lab IPO Size
| Types | Size (₹Cr) |
|---|---|
| Total IPO size | 44.68 |
| Offer for sale | 2.12 |
| Fresh issue | 42.55 |
Ambey Lab IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 2000 | ₹136,000 |
| Retail (Max) | 1 | 2000 | ₹136,000 |
| S-HNI (Min) | 2 | 4000 | ₹272,000 |
Ambey Lab IPO Reservation
| Investors Category | Subscription (times) | Shares Offered | Shares bid for | Total Amount (Cr.) |
|---|---|---|---|---|
| QIB | 61.90 | 1,252,000 | 7,74,96,000 | 526.97 |
| NII (HNI) | 324.02 | 606,001 | 19,63,56,000 | 1,335.22 |
| Retail | 194.18 | 2,184,000 | 42,40,88,000 | 2,883.80 |
| Total | 172.67 | 4,042,001 | 69,79,40,000 | 4,745.99 |
Ambey Lab IPO Anchor Allocation
| Anchor Bid Date | 3 July 2024 |
| Total no. of shares offered | 1,872,000 |
| Portion Size for Anchor Investors | 12.73 Cr. |
| Lock in Period for 50% shares (30 days) | 8 August 2024 |
| Lock in Period for rest of shares (90 days) | 7 October 2024 |
Ambey Laboratories manufactures agrochemical products that protect crops. The company produces and sells s '2,4-D base chemicals as per Environmental, Health, and Safety (EHS) regulations. Its manufacturing unit is based in Behror, Rajasthan, India.
Some of the popular products manufactured by Ambey are 2,4-D Acid 98% TC, 2,4-D Sodium 95% SP 2,4-D Amine 866 | 720 | 480g/l SL 2,4-D Ethyl Hexyl Ester 96% TC 2,4-D Ethyl Ester 96% TC Chlorpyriphos 97%TC / 20%EC / 50%EC Thiamethoxam 96%TC / 25%WG / 75%SG Pretilachlor 95%TC / 50%EC / 37%EW Metribuzin 140 97%TC / 70%WS Hexaconazole 92%TC / 5%SC / 5%EC / 10%EC and Metalaxyl 98%TC / 35%WS. It supplies these products to clients like Aromatic Rasayan Private Limited, JR Jindal Infra-projects Private Limited, SC Formulator Co. Ltd. and more.
It also has various certifications like ISO 9001:2015 and ISO 14001:2015, as well as various other accreditations and recognition from renowned organizations across the globe. The company has implemented backward integration for ZLD (Zero Liquid Discharge).
Peer Comparison
● Atul Limited
● Meghmani Organics Limited
For More Information
Webstory on Ambey Laboratories IPO
| Particulars (in Rs. Crores) | FY23 | FY22 | FY21 |
|---|---|---|---|
| Revenue from operations | 104.82 | 84.60 | 81.73 |
| EBITDA | 11.02 | 10.85 | 10.40 |
| PAT | 4.56 | 3.57 | 10.33 |
| Particulars (in Rs. Crores) | FY23 | FY22 | FY21 |
|---|---|---|---|
| Total Assets | 57.61 | 55.92 | 44.61 |
| Share Capital | 17.74 | 17.74 | 4.89 |
| Total Borrowings | 33.98 | 36.86 | 52.48 |
| Particulars (in Rs. Crores) | FY23 | FY22 | FY21 |
|---|---|---|---|
| Net cash generated from / (used in) operating activities | 9.44 | 5.60 | 2.74 |
| Net cash from / (used in) investing activities | -3.08 | -0.75 | -1.16 |
| Net cash flow from / (used in) financing activities | -6.23 | -5.07 | -1.49 |
| Net increase (decrease) in cash and cash equivalents | 0.12 | -0.22 | 0.085 |
Strengths
1. The company’s manufacturing unit is strategically located.
2. Quality Assurance Standards are strictly followed.
3. It has cordial relationships with suppliers.
4. Experienced promoters and management team.
Risks
1. The company requires a number of approvals, licenses, registrations and permits to run the business.
2. The business is seasonal in nature.
3. It has reported negative cash flow in the past.
4. It operates in a competitive industry.
in 3
easy steps
Using 5paisa App or
Website
to block Payment
Open Free Demat Account
Be a part of 5paisa community - The first listed discount broker of India.
FAQs
Ambey Laboratories IPO opens from 4th July to 8th July 2024.
The size of Ambey Laboratories IPO is ₹44.68 cr.
To apply for Ambey Laboratories IPO, follow the steps given below:
● Login to your 5paisa account and select the issue in the current IPO section
● Enter the number of lots and the price at which you wish to apply for Ambey Laboratories IPO.
● Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.
You will receive a mandate notification to block funds in your UPI app.
The price band of Ambey Laboratories IPO is fixed at ₹65 to ₹68 per share.
The minimum lot size of Ambey Laboratories IPO is 2000 shares and the investment required is ₹ 136,000.
The share allotment date of Ambey Laboratories IPO is 9th July 2024.
The Ambey Laboratories IPO will be listed on 11th July 2024.
Fast Track Finsec Private Limited is the book-running lead manager for Ambey Laboratories IPO.
Ambey Laboratories plans to utilize the raised capital from the IPO to:
● To fund Working Capital Requirements.
● General corporate purposes.
● To fund the public issue expenses.
